Cerebral Palsy (Spastic Diplegia)

I am often asked: what is it like to have cerebral palsy? The truth is, of course, that it affects every person differently but the major types of cerebral palsy have general characteristics, which affect most of us to some extent. Spastic diplegia is the type of cerebral palsy I have and with which Serrapeptase is helping me to live.

Cerebral palsy can be traced to a problem with the brain’s white matter, the wiring in the brain that sends messages to the muscles. Because of damage to the white matter, it is easily overloaded. The messages that go out to the muscles are in constant conflict leaving a person with little control over them. Although it is known that the brain is damaged at birth, the exact cause is not known. It could have been a result of maternal infection during pregnancy or of a problem during a premature birth. For years, many cases of cerebral palsy have been attributed to suffocation (asphyxia) during birth, but recent studies have indicated that this problem accounts for only a minority of cases.

Conventional medicine says that the damage will not get worse, but equally it will not get better. However, over time, the wear-and-tear it causes often makes other, unrelated, conditions more difficult to manage. It is this secondary damage, with which Serrapeptase has been the most help.

The mechanics of everyday movement, which most people take for granted, are extremely difficult and sometimes impossible. In normal walking, for example, contractions of opposite muscles alternate. Walking, unaided, requires the coordinated control of two hundred muscles, but basically, muscles at the front of the leg tighten and shorten, and then those at the back do the same in natural rhythm. In the case of someone with cerebral palsy, opposing muscles simultaneously contract; muscles that should co-operate are in a constant tug-of-war, so that every step is a struggle. The constant muscle tension caused by cerebral palsy is exhausting and can cause excruciating pain.

Although the label spastic diplegia indicates that the principal damage caused by the cerebral palsy affects two limbs, of the same type, meaning both arms or both legs and not one of each, it is very rarely limited completely to one area. For me, it has affected my legs dramatically, but there is some minor effect on my hands.

In common with many people with cerebral palsy, I was also born with poor eyesight and poor visual perception. Since these visual and perceptual problems are part of the original brain damage, conventional medicine believes them to be fixed, and beyond repair.

My Serrapeptase Adventure continues to surprise me with the remarkable potential of the human body to heal and to find new ways of overcoming the obstacles that cannot be removed.

I still have cerebral palsy and I will always have to live with it and to overcome it as much as possible. I am privileged to have been given the opportunity, with the help of ‘the miracle enzyme’, Serrapeptase, and the constant encouragement and support of many remarkable people, to reverse much of the accumulated damage to my body, which occurred because of cerebral palsy, despite not being directly caused by it.

Remarkably, since November 2006, my poor eyesight and visual perception, which were directly caused by the brain damage of cerebral palsy, have also improved dramatically and continue to do so.

Despite the wisdom of conventional medicine, which believes that the remarkable improvements in my health, mobility and even my eyesight, should not be possible, it is the testing and measurement regimes so favoured by conventional medicine, which have done so much to disprove themselves.

In December 2005, I was taking a multitude of prescription medications every day, and my health was becoming measurably, and steadily worse.

Now, I take no prescription medication at all and my health, mobility, eyesight and visual perception continue to improve, and my enthusiasm for life increases every day.

Previous Next

Your email address will not be published. Required fields are marked *